NASD | Health Care | Biotechnology

Iovance Biotherapeutics, Inc. (IOVA)

LAST (3 Apr)
3.25
-0.29  (-8.19%)
After-Hours (19:59:46 ET)
3.27
+0.02  (+0.62%)
MARKET CAP
1.063 B
VOLUME
10,831,168
ENTER A SYMBOL
MEMBER ACTIONS
Summary as of: 3 Apr
Open 3.31
Previous Close 3.54
Day Range 3.19 - 3.37
52-Week Range 3.18 - 14.23
All-Time High 165.00
Avg. Volume (50-day) 9,453,734
EPS (TTM) -1.30
Next Earnings Date 2025-05-08 (AMC)
Last Earnings Date 2025-02-27
Forward Annual Dividend (Yield) -
Trailing Annual Dividend (Yield) -
Options Yes
Fundamentals
P/E Ratio -2.73
PEG Ratio -
Price to Book 1.52
Price to Cash Flow -
Price to Free Cash Flow -
Total Sales (TTM) 164.07 M
Revenue per Share (TTM) 0.54
Shares Outstanding 327.877 M
Share Float (%) 265.54 M (80.99%)
% Held by Institutions 65.43
Dividends Per Share (TTM) -
Ex-Dividend Date -
Technicals
+/- EMA(20) 3.7 (-12.16%)
+/- SMA(50) 4.69 (-30.70%)
+/- SMA(200) 7.96 (-59.17%)
5-Day Perf. -10.47%
1-Month Perf. -19.55%
3-Month Perf. -57.52%
6-Month Perf. -66.7%
YTD Perf. -56.08%
1-Year Perf. -76.8%
RSI(14) 33.5
ATR(14) 0.28
ADX(14) 29.39
Beta (5Y) 1.27
Earnings NEW

FOR STOCKCHARTS MEMBERS ONLY

Unlock earnings and revenue history when you join StockCharts

As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!

SCTR Rank SCTR Reports  

IOVA

11.1
(-0.1)
SCTR Universe: Small Cap
Click Here for more info about the StockCharts Technical Rankings (SCTRs)
Profile

Iovance Biotherapeutics, Inc.

825 Industrial Road, Suite 400
San Carlos, California
http://www.iovance.com
Sector: Health Care
Industry: Biotechnology
Employees: 838
Description

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Predefined Scans with IOVA View All  
Alerts for IOVA View All   New

FOR STOCKCHARTS MEMBERS ONLY

Unlock custom technical alerts when you join StockCharts

As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.

ChartLists with IOVA

FOR STOCKCHARTS MEMBERS ONLY

Unlock ChartLists to save and organize your charts when you join StockCharts

As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.